St Jude Medical Inc (STJ)

STJ (NYSE:Health Services)
$62.51
pos +0.67
+1.08%
Today's Range: 61.66 - 62.73 | STJ Avg Daily Volume: 2,143,400
Last Update: 04/24/14 - 4:02 PM EDT
Volume: 1,741,144
YTD Performance: -0.18%
Open: $62.28
Previous Close: $61.84
52 Week Range: $40.55 - $68.79
Oustanding Shares: 283,804,872
Market Cap: 17,868,866,023
6-Month Chart
TheStreet Ratings Grade for STJ
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 13 13 13 11
Moderate Buy 1 0 0 0
Hold 6 7 7 10
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.79 1.86 1.86 2.09
Latest Dividend: 0.27
Latest Dividend Yield: 1.61%
Dividend Ex-Date: 03/27/14
Price Earnings Ratio: 17.89
Price Earnings Comparisons:
STJ Sector Avg. S&P 500
17.89 24.50 29.23
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-3.06% 50.94% 17.54%
GROWTH 12 Mo 3 Yr CAGR
Revenue 0.00 0.07 0.02
Net Income -8.00 -0.24 -0.09
EPS 4.20 -0.09 -0.03
Earnings for STJ:
EBITDA 1.65B
Revenue 5.50B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.00 $0.96 $3.98 $4.32
Number of Analysts 13 13 15 14
High Estimate $1.02 $0.98 $4.00 $4.42
Low Estimate $0.99 $0.93 $3.96 $4.24
Prior Year $0.96 $0.90 $3.76 $3.98
Growth Rate (Year over Year) 4.33% 6.32% 5.90% 8.60%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bullishSt. Jude upgraded at William Blair

Feb 10, 2014 | 7:51 AM EST

STJ was upgraded to Outperform, William Blair said. New product portfolio should drive growth in the coming quarters. 

bullishSt. Jude upgraded at Stifel

Feb 10, 2014 | 7:18 AM EST

STJ was upgraded from Hold to Buy, Stifel Nicolaus said. $75 price target. Company can show accelerating sales growth and expanding margins. 

 

updateSTJ Investor Mtg.

Feb 7, 2014 | 7:19 AM EST

STJ - St. Jude Medical, Inc. 2014 Investor Meeting - 8AM 

bullishSt. Jude upgraded at Morgan Stanley

Jan 6, 2014 | 8:22 AM EST

STJ was upgraded from Equal-weight to Overweight, Morgan Stanley said. $75 price target. Organic growth is accelerating. 

updateSt. Jude Medical upgraded at BMO

Dec 16, 2013 | 8:08 AM EST

STJ was upgraded to Outperform from Marketperform, BMO said. Benefits from improving ICD market, FDA approval of CardioMEMS, and new product launches. $66 price target.

By

Scott Redler

 | Oct 1, 2013 | 6:54 PM EDT

Maintain a stock-specific approach until a clearer trend develops.

bullishSt. Jude upgraded at Wells

Aug 9, 2013 | 8:25 AM EDT

STJ was upgraded from Market Perform to Outperform, Wells Fargo said. CardioMEMS will likely receive U.S. approval and the stock is the cheapest in the industry. 

bullishSt. Jude numbers boosted at BMO

Jul 18, 2013 | 8:12 AM EDT

Shares of STJ now seen reaching $52, according to BMO Capital Markets. Estimates also upped, given the company's new guidance. Market Perform rating. 

By

Doug Kass

 | Jul 17, 2013 | 8:18 AM EDT
Let's take a peek at overnight and early-morning price action in the major asset classes.

bearishSt. Jude Medical downgraded at Canaccord

May 28, 2013 | 7:55 AM EDT

STJ was downgraded from Hold to Sell, Canaccord Genuity said. $35 price target. Earnings quality is declining and the company is facing increased competition. 

CH Robinson has had a higher gap opening the last four days in a row. Boy, someone really ...
The wicked, whipsaw action following FB's earnings release last evening warns me the stock...
This stock has been a dog for years, but its ears are perking here lately, and today has m...
Good afternoon! Oil has taken a swift turn this week and is showing further weakness ahead...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.